Skip to content
Delayed ~15 min

BCPC BALCHEM

Permanent stock page ↗

Industrials · Russell 2000

Next earnings: not announced yet

What 7 analyst firms say about BALCHEM: their latest ratings, price targets and how far the stock is from them. How it works

174.43 USD−5.28 (−2.94%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+13.7%to the avg target 198.33 USD+23.90 USD
Buy 3 · Hold 3 · Sell 0

6 rated views · 7 analyst/firm records · 7 firms

Latest report23 Oct 2026avg report date 17 Jun
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)

Recent analyst activity · last 90 days

Our tracked history has 3 reports on BCPC from 3 analyst firms in the last 90 days (7 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target.

No firm's latest available rating differs from its previous one.

Latest observed target change: HC Wainwright raised its target from $5.16 (set 4 May 2026) to $210.00 on 23 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cjs SecuritiesUnnamed analystBuy11 Dec 2025—
H.C. WainwrightRaghuram SelvarajuBuy23 Oct 2026210.00 USD
RedburnArtem ChubarovHold11 Aug 2026165.00 USD
SidotiDaniel HarrimanHold16 Dec 2025220.00 USD
UBSUnnamed analystBuy3 Aug 2026—
Weiss RatingsUnnamed analyst—21 Sep 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 04:10 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.